{"id":912098,"date":"2025-11-20T08:25:43","date_gmt":"2025-11-20T13:25:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/"},"modified":"2025-11-20T08:25:43","modified_gmt":"2025-11-20T13:25:43","slug":"opus-genetics-to-participate-in-upcoming-investment-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/","title":{"rendered":"Opus Genetics to Participate in Upcoming Investment Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>RESEARCH TRIANGLE PARK, N.C., Nov.  20, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VAit_fLVxs2TdxxhnEwY1nXS0QO7hwlR-6R-jJW67M5RhANon_tbcnfzld6x3YPWZFS7mmaaPiCiL53EzrhEvQw9TJs8XVZYAMSxNtaBsM4=\" rel=\"nofollow\" target=\"_blank\">Opus Genetics, Inc.<\/a> (Nasdaq: IRD) (the \u201cCompany\u201d or \u201cOpus Genetics\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will participate in the following investor conferences.<\/p>\n<p>\n        <strong>BTIG 5<\/strong><br \/>\n        <sup><br \/>\n          <strong>th<\/strong><br \/>\n        <\/sup><br \/>\n        <strong> Annual Ophthalmology Day (Virtual): <\/strong>Ash Jayagopal, PhD, MBA, Chief Scientific and Development Officer, will participate in a fireside chat on Monday, December 1, 2025, at 1:00 p.m. ET.<\/p>\n<p>\n        <strong>Piper Sandler 37th Annual Healthcare Conference: <\/strong>George Magrath, M.D., Chief Executive Officer, will participate in a fireside chat on Tuesday, December 2, 2025, at 10:00 a.m. ET in New York, NY.<\/p>\n<p>A link to the live and archived webcast for the Piper Sandler conference may be accessed on Opus Genetics\u2019 website under the Investors section: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MNfwlcAGbu7RaKeXinvgcGM-iF6Y-QLU3MHiMHmJMsKsF8eAboeAlNJJXhoJn_OTL4y1G0uazO6_bd1bY8_wvA==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>.<\/p>\n<p>\n        <strong>About Opus Genetics<\/strong>\n      <\/p>\n<p>Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is developing durable, one-time treatments designed to address the underlying genetic causes of severe retinal disorders. The Company\u2019s pipeline includes seven AAV-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RHO, RDH12, and MERTK. Opus Genetics is also advancing Phentolamine Ophthalmic Solution 0.75%, an approved small-molecule therapy for pharmacologically induced mydriasis, with additional indications in late-stage development for presbyopia and low-light visual disturbances following keratorefractive surgery. The Company is based in Research Triangle Park, NC. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O5GVCDdV68oQ12XxcZ5cebUmcfn3ArXXzPYbjxwuke9PrlVTHTkYJucSsjJXqsobItmyfyjSHVlJIxuEVOCYmg==\" rel=\"nofollow\" target=\"_blank\">www.opusgtx.com<\/a>.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>\n        <strong>Investors<\/strong><br \/>\n        <br \/>Jenny Kobin<br \/>Remy Bernarda<br \/>IR Advisory Solutions<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5AIRIVGFJChAogJr98WPWR0T3MfsO-Cg-iQc7_aTueRmy-j-lso6qm7jp10rQj_IfUJQN5mslD8VdhGQlTkgoQ==\" rel=\"nofollow\" target=\"_blank\">ir@opusgtx.com<\/a><\/p>\n<p>\n        <strong>Media<\/strong><br \/>\n        <br \/>Kimberly Ha<br \/>KKH Advisors<br \/>917-291-5744<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DqAm7XL-pSlxMUw066HD0qjC4GEiS5Jm8l2qFossynggx69aKUrikbvkK3OdU22ZH-_VzVoiXn4XKqLJ7IhDoxBsk9ImNM2s5rgfCnfjtz0-vW-jixtwIfoQ7zzx5R7t\" rel=\"nofollow\" target=\"_blank\">kimberly.ha@kkhadvisors.com<\/a><\/p>\n<p>Source: Opus Genetics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MGVhMjJiOGEtODQ1Ni00MTViLTk3YzktNDI4NmExNzRjYTQ2LTEzMTMzMTAtMjAyNS0xMS0yMC1lbg==\/tiny\/Opus-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (the \u201cCompany\u201d or \u201cOpus Genetics\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will participate in the following investor conferences. BTIG 5 th Annual Ophthalmology Day (Virtual): Ash Jayagopal, PhD, MBA, Chief Scientific and Development Officer, will participate in a fireside chat on Monday, December 1, 2025, at 1:00 p.m. ET. Piper Sandler 37th Annual Healthcare Conference: George Magrath, M.D., Chief Executive Officer, will participate in a fireside chat on Tuesday, December 2, 2025, at 10:00 a.m. ET in New York, NY. A link to the live and archived &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Opus Genetics to Participate in Upcoming Investment Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-912098","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opus Genetics to Participate in Upcoming Investment Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opus Genetics to Participate in Upcoming Investment Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (the \u201cCompany\u201d or \u201cOpus Genetics\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will participate in the following investor conferences. BTIG 5 th Annual Ophthalmology Day (Virtual): Ash Jayagopal, PhD, MBA, Chief Scientific and Development Officer, will participate in a fireside chat on Monday, December 1, 2025, at 1:00 p.m. ET. Piper Sandler 37th Annual Healthcare Conference: George Magrath, M.D., Chief Executive Officer, will participate in a fireside chat on Tuesday, December 2, 2025, at 10:00 a.m. ET in New York, NY. A link to the live and archived &hellip; Continue reading &quot;Opus Genetics to Participate in Upcoming Investment Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-20T13:25:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Opus Genetics to Participate in Upcoming Investment Conferences\",\"datePublished\":\"2025-11-20T13:25:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/\"},\"wordCount\":286,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/\",\"name\":\"Opus Genetics to Participate in Upcoming Investment Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=\",\"datePublished\":\"2025-11-20T13:25:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-participate-in-upcoming-investment-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opus Genetics to Participate in Upcoming Investment Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opus Genetics to Participate in Upcoming Investment Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Opus Genetics to Participate in Upcoming Investment Conferences - Market Newsdesk","og_description":"RESEARCH TRIANGLE PARK, N.C., Nov. 20, 2025 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (the \u201cCompany\u201d or \u201cOpus Genetics\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), announced today that management will participate in the following investor conferences. BTIG 5 th Annual Ophthalmology Day (Virtual): Ash Jayagopal, PhD, MBA, Chief Scientific and Development Officer, will participate in a fireside chat on Monday, December 1, 2025, at 1:00 p.m. ET. Piper Sandler 37th Annual Healthcare Conference: George Magrath, M.D., Chief Executive Officer, will participate in a fireside chat on Tuesday, December 2, 2025, at 10:00 a.m. ET in New York, NY. A link to the live and archived &hellip; Continue reading \"Opus Genetics to Participate in Upcoming Investment Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-20T13:25:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Opus Genetics to Participate in Upcoming Investment Conferences","datePublished":"2025-11-20T13:25:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/"},"wordCount":286,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/","name":"Opus Genetics to Participate in Upcoming Investment Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=","datePublished":"2025-11-20T13:25:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3OTI4MyM3Mjc0MjgyIzIzMDE3NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-participate-in-upcoming-investment-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Opus Genetics to Participate in Upcoming Investment Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=912098"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/912098\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=912098"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=912098"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=912098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}